Revisiting Skull Metastases of Prostate Cancer at Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography Era: PSMA Uptake Characteristics and Oncological Outcomes. [PDF]
Esen B +9 more
europepmc +1 more source
Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin. [PDF]
Kuzmanov A +3 more
europepmc +1 more source
Prostate-Specific Membrane Antigen (PSMA) Uptake in the Scrotum and Epididymis on PET-CT: When is it Pathological? [PDF]
Singh D, Badya R, Drew Z.
europepmc +1 more source
Prostate specific membrane antigen focal ablation imaging (PSMA-FAB)
Egesta Lopci +12 more
openaire +1 more source
Does total lesion prostate-specific membrane antigen (PSMA) activity on <sup>68</sup>Ga-PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer? [PDF]
Cheng J +7 more
europepmc +1 more source
The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer. [PDF]
Al Saffar H +8 more
europepmc +1 more source
Exosomal Prostate-Specific Membrane Antigen (PSMA) and Caveolin-1 as Potential Biomarkers of Prostate Cancer-Evidence from Serbian Population. [PDF]
Matijašević Joković S +10 more
europepmc +1 more source
Distinguishing Physiological Ureter Uptake From an Involved Lymph Node in Staging Prostate-Specific Membrane Antigen (PSMA) Scans: Implications for Radiation Planning. [PDF]
Ching L +8 more
europepmc +1 more source
<sup>68</sup>Ga-prostate-specific membrane antigen (PSMA) and <sup>68</sup>Ga-DOTA0-Tyr3-octreotate (DOTATATE) positron emission tomography/computed tomography (PET/CT) in a case of metastatic castration-resistant prostate cancer (mCRPC) with low prostate-specific antigen (PSA) and reduced <sup>18</sup>F-fluorodeoxyglucose (FDG) uptake after endocrine therapy. [PDF]
Li L, Chen Y, Zou L.
europepmc +1 more source

